Try our Advanced Search for more refined results
July 07, 2021
Bayer Healthcare LLC et al v. Dr. Reddy's Laboratories, Inc. et al
Case Number:
1:21-cv-00997
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 18, 2021
Bayer, Amgen Unit Drop IP Suit Over Cancer Drug Generic
Bayer and Amgen's Onyx Pharmaceuticals on Thursday told a Delaware federal judge that they no longer wish to pursue patent litigation against Dr. Reddy's for attempting to bring a generic version of the cancer drug Nexavar to market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login